Figure 10From: Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human gliomaEffects of SLC22A18 expression on tumor growth in vivo. (A) Subcutaneous tumor model. a, U251 cells group; b, U251-EV cells group; c, U251-SLC22A18 cells group. (B) Tumor growth curves of each group over 28 days.Back to article page